PT Royal Prima Tbk (ISX:PRIM) Altman Z2-Score: 11.30 (As of Aug. 29, 2026) — 29% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PRIM PT Royal Prima Tbk ISX:PRIM
73 GF Score
Price Rp120.00
GF Value Rp77.92
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is PT Royal Prima Tbk Altman Z2-Score?

PT Royal Prima Tbk ISX:PRIM +0.84% 73 Altman Z2-Score is 11.30 as of Aug. 29, 2026, which is 29% below its 10-year median of 15.95. GuruFocus rates ISX:PRIM with a GF Score™ of 73/100 and a GF Value™ of Rp77.92 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 626 Healthcare Providers & Services companies, PT Royal Prima Tbk ranks better than 92.97% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

PT Royal Prima Tbk has a Altman Z2-Score of 11.30, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for PT Royal Prima Tbk's Altman Z2-Score or its related term are showing as below:

ISX:PRIM' s Altman Z2-Score Range Over the Past 10 Years
Min: 8.11   Med: 15.95   Max: 23.4
Current: 11.3

During the past 12 years, PT Royal Prima Tbk's highest Altman Z2-Score was 23.40. The lowest was 8.11. And the median was 15.95.


PT Royal Prima Tbk  (ISX:PRIM) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


PT Royal Prima Tbk Altman Z2-Score Related Terms


PT Royal Prima Tbk Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for PT Royal Prima Tbk's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Royal Prima Tbk Altman Z2-Score Chart

PT Royal Prima Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.18 21.55 22.05 9.02 10.11

PT Royal Prima Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.55 9.93 10.11 10.82 11.30

ISX:PRIM vs HCA, THC, DVA: Altman Z2-Score Comparison

For the Medical Care Facilities subindustry, PT Royal Prima Tbk's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Royal Prima Tbk Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Royal Prima Tbk's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where PT Royal Prima Tbk's Altman Z2-Score falls into.


ISX:PRIM
73GF Score
PT Royal Prima Tbk ISX:PRIM
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Royal Prima Tbk Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

PT Royal Prima Tbk's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.0998+3.26*0.1342+6.72*-0.0183+1.05*9.8388
=11.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Jun. 2026:
Total Assets was Rp1,033,304 Mil.
Total Current Assets was Rp181,104 Mil.
Total Current Liabilities was Rp77,973 Mil.
Retained Earnings was Rp138,661 Mil.
Pre-Tax Income was 1265.874 + -2228.121 + -16619.29 + -1708.511 = Rp-19,290 Mil.
Interest Expense was -219.186 + -112.589 + -14.187 + -9.779 = Rp-356 Mil.
Total Liabilities was Rp95,245 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(181104.354 - 77973.429)/1033303.755
=0.0998

X2=Retained Earnings/Total Assets
=138660.768/1033303.755
=0.1342

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-19290.048 - -355.741)/1033303.755
=-0.0183

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(937098.578 - 0)/95245.115
=9.8388

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

PT Royal Prima Tbk has a Altman Z2-Score of 11.30 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 11.30 mean?
PT Royal Prima Tbk (ISX:PRIM) has a Altman Z2-Score of 11.30 as of Aug. 29, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on PT Royal Prima Tbk and its competitors. This is 29% below median its historical median of 15.95. Over the past decade, PT Royal Prima Tbk's Altman Z2-Score has ranged from 8.11 to 23.40. According to the industry distribution chart, PT Royal Prima Tbk ranks #44 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 7%.
Is PT Royal Prima Tbk's Altman Z2-Score too high?
PT Royal Prima Tbk's current Altman Z2-Score of 11.30 is 29% below median its 10-year median of 15.95. Over the past 10 years, this metric has ranged from a low of 8.11 to a high of 23.40. The Healthcare Providers & Services industry median Altman Z2-Score is 2.10. PT Royal Prima Tbk's value of 11.30 is 438.1% above this industry median. Based on the distribution chart, PT Royal Prima Tbk ranks #44 out of 626 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PT Royal Prima Tbk has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Royal Prima Tbk's Altman Z2-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Royal Prima Tbk ranks #44 out of 626 companies for Altman Z2-Score. This places PT Royal Prima Tbk in the top 7% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 2.10. PT Royal Prima Tbk's value of 11.30 is 438.1% above this benchmark. Historically, PT Royal Prima Tbk's own Altman Z2-Score has ranged from 8.11 to 23.40 over the past decade. While the company's 10-year median is 15.95 vs. the industry median of 2.10, PT Royal Prima Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.10, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Royal Prima Tbk's current Altman Z2-Score of 11.30 is 438.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on PT Royal Prima Tbk and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Royal Prima Tbk's current Altman Z2-Score is 11.30, which is 29% below median its own 10-year median of 15.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Royal Prima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Royal Prima Tbk (ISX:PRIM) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp77.92, compared to a current price of Rp120.00 — trading 54% above its estimated fair value. The current Altman Z2-Score is 11.30, which is 29% below median its 10-year median of 15.95 and 438.1% above the Healthcare Providers & Services industry median of 2.10. PT Royal Prima Tbk's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For PT Royal Prima Tbk (ISX:PRIM), the current Altman Z2-Score is 11.30 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?

Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued. The current stock price of Rp120.00 is trading 54% above its estimated GF Value™ of Rp77.92. GuruFocus considers PT Royal Prima Tbk to be Significantly Overvalued.

Key valuation signals for ISX:PRIM:

  • Altman Z2-Score: 11.30 (29% below median its 10-year median of 15.95)
  • GF Value™: Rp77.92 vs. price of Rp120.00 (54% above fair value)
  • GF Score™: 73/100 with 6 warning signs
  • Industry Position: 438.1% above the Healthcare Providers & Services median (#44 of 626)

No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Royal Prima Tbk Business Description

Address Jalan. Ayahanda No. 68A, Sumatera Utara, Medan, IDN, 20118
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
73GF Score

Get the complete analysis for ISX:PRIM

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp120.00
Price
Rp77.92
GF Value